2018 AAHKS Annual Meeting

Abstracts Archives

The following abstracts were presented at the podium during the 2018 AAHKS Annual Meeting from November 1-4, 2018 at the Hilton Anatole in Dallas. Download the PDF of the Final Program Book and download the final list of disclosures.

AAHKS Awards

The James A. Rand Young Investigator’s Award

Large Opioid Prescriptions are Unnecessary After Total Joint Arthroplasty: A Randomized Controlled Trial
Presenter: Charles P. Hannon, MD
Co-Authors: Tyler E. Calkins, BS; Jefferson Li, BA; Chris Culvern, MS; Brian Darrith, MD; Denis Nam, MD, MSc; Tad L. Gerlinger, MD; Craig J. Della Valle, MD

The Lawrence D. Dorr Surgical Techniques & Technologies Award

Why Are Contemporary Revision Total Hip Arthroplasties Failing? An Analysis of 2500 Cases
Presenter: Ashton H. Goldman, MD
Co-Authors: Rafael J. Sierra, MD; Robert T. Trousdale, MD; David G. Lewallen, MD; Daniel J. Berry, MD; Matthew P. Abdel, MD

The AAHKS Clinical Research Award

Prophylactic Tamsulosin Does Not Reduce the Risk of Urinary Retention Following Lower Extremity Arthroplasty: A Double-Blind Randomized Controlled Trial
Presenter: Aidin Eslam Pour, MD, MS
Co-Authors: Manuel Schubert, MD; Jared Thomas, MD; Joel Gagnier, PhD; Caitlin McCarthy, BS; John Lee, MD; Andrew G. Urquhart, MD

Podium Abstracts in Order of Presentation

  1. No Difference in Five-Year Clinical and Radiographic Outcomes Between Kinematic and Mechanical Alignment in TKA – A Randomized Controlled Clinical Trial
    Matthew Walker, FRACS
  2. To Cement or Not? Five-Year Update of a Prospective Randomized Trial Comparing Cemented vs. Cementless Total Knee Arthroplasty
    Kevin B. Fricka, MD
  3. A Prospective, Randomized Trial of Cemented vs. Cementless Total Knee Arthroplasty of the Same, Modern Design
    Denis Nam, MD, MSc
  4. Physical Therapy on Postoperative Day 0 Following Total Knee Arthroplasty: A Randomized Controlled Trial of 394 Patients
    Tyler E. Calkins, MS
  5. The Effect of Topical and Intravenous Tranexamic Acid on Drug Levels in Patients Undergoing Total Knee Arthroplasty: A Randomized Double-Blind Placebo Controlled Study
    David J. Mayman, MD
  6. Intraoperative Ketamine During Total Knee Arthroplasty: A Prospective Randomized Controlled Trial
    Eric Levicoff, MD
  7. Is Operative Time a Predictor for Postoperative Infection Following Total Knee Arthroplasty?
    Hiba Anis, MD
  8. Preoperative Weight Loss for Morbidly Obese Patients Undergoing Total Knee Arthroplasty: How Much Is Necessary?
    Benjamin J. Keeney, PhD
  9. Evaluation of the Spine Is Critical in Patients with Recurrent Instability After Total Hip Arthroplasty
    Jonathan M. Vigdorchik, MD
  10. IV Tranexamic Acid (TXA) Effectively and Safely Reduces Transfusion Rates in Revision Total Hip Arthroplasties
    Jeremy T. Hines, MD
  11. Safety of Tranexamic Acid in Patients with Comorbidities: A National Assessment Using Claims Data from 1.7 Million Hip and Knee Arthroplasties
    Calin S. Moucha, MD
  12. Multicenter Evaluation of a Modular Dual Mobility Construct for Revision Total Hip Arthroplasty
    Ronald C. Huang, MD
  13. Mid-Term Results of Dual Mobility for Monoblock Metal-on-Metal Revision – Is It Safe?
    Nicholas D. Colacchio, MD
  14. Constrained Liner Revision Is Less Effective with Each Subsequent Constrained Liner Revision at Preventing Instability in Revision Total Hip Arthroplasty
    Nicholas M. Hernandez, MD
  15. IV vs. Oral Acetaminophen as a Component of Multimodal Analgesia After Total Hip Arthroplasty: A Randomized, Double-Blinded, Controlled Trial
    Geoffrey H. Westrich, MD
  16. Evaluation of Vitamin E Diffused Highly Crosslinked Polyethylene Wear and Porous Titanium Coated Shell Stability: A Seven-Year Randomized Control Trial using Radiostereometric Analysis
    Orhun K. Muratoglu, PhD
  17. Posterior Hip Precautions Do Not Impact Early Recovery at Total Hip Arthroplasty: A Multicenter Randomized Controlled Study
    Matthew J. Dietz, MD
  18. Time to Dislocation Analysis of Lumbar Spine Fusion Following Total Hip Arthroplasty: Breaking Up a Happy Home
    Connor A. King, MD
  19. Primary Total Hip Arthroplasty Instability Following Lumbosacral Fusion: What Are the Risk Factors?
    Matthew P. Siljander, MD
  20. Dynamic Sitting to Standing Radiographs More Accurately Depict Functional Mechanics Than Static Radiographs in Total Hip Arthroplasty
    Aaron Buckland, MD
  21. Cluster-Randomized Trial of Opiate-Sparing Analgesia After Discharge from Elective Hip Surgery
    Antonia F. Chen, MD, MBA
  22. Primary Total Hip Arthroplasty in Patients Less than 50 Years of Age at a Mean of 16 Years
    Andrew J. Bryan, MD
  23. Perioperative Periprosthetic Femur Fractures Are Strongly Correlated with Fixation Method: An Analysis from the American Joint Replacement Registry (AJRR)
    Bryan D. Springer, MD
  24. Does Taper Design Affect Taper Fretting Corrosion in Ceramic on Polyethylene Total Hip Arthroplasty? A Retrieval Analysis
    Ali Sobh, MD
  25. Higher Volume Surgeons Have Lower Cost, Readmissions and Mortality After THA
    Stephen B. Murphy, MD
  26. The Effect of Body Mass Index in 30-Day Complications After Revision Total Hip and Total Knee Arthroplasty
    Nicolas S. Piuzzi, MD
  27. Perioperative Antibiotic Prophylaxis in Total Joint Arthroplasty: A Single Dose Is as Effective as Multiple Doses
    Timothy L. Tan, MD
  28. What Is the Role of Repeat Aspiration in the Diagnosis of Periprosthetic Hip Infection?
    Adam J. Schwartz, MD, MBA
  29. Diagnostic Accuracy of the Alpha-Defensin Test for Periprosthetic Joint Infection in Patients with Inflammatory Diseases
    Yushi Miyamae, MD
  30. Failed Debridement and Implant Retention Does Not Compromise Success of Subsequent Staged Revision in Infected Total Knee Arthroplasty
    Simon W. Young, FRCS
  31. Nationwide Organism Susceptibility Patterns to Common Preoperative Prophylactic Antibiotics: What Are We Covering?
    Scott R. Nodzo, MD
  32. Hepatitis C May Be a Modifiable Risk Factor in Total Joint Arthroplasty: Preoperative Treatment of Hepatitis C is Associated with Decreased Post-Operative Complications in US Veterans
    Ilya Bendich, MD
  33. A Multi-Center Randomized Clinical Trial of Tranexamic Acid in Revision Total Knee Arthroplasty:  Does the Dosage Regimen Matter?
    Yale A. Fillingham, MD
  34. Topical Tranexamic Acid in Revision Total Knee Arthroplasty Reduces Transfusion Rates and May Be Associated with Earlier Functional Recovery
    Alejandro Gonzalez Della Valle, MD
  35. Next Generation Sequencing for the Diagnosis of Periprosthetic Knee Infection: A Multicenter Investigation
    Karan Goswami, MD
  36. Does Neutral Mechanical Alignment Improve the Durability of Revision Total Knee Arthroplasty?
    Matthew P. Abdel, MD
  37. Ignore the Patella in Revision Total Knee Surgery
    David F. Dalury, MD
  38. What Is the Value of Component Loosening Assessment of a Preoperatively-Obtained Bone Scan Prior to Revision Total Knee Arthroplasty?
    David C. Holst, MD
  39. Natural History of the Dysplastic Hip Following Periacetabular Osteotomy
    Cody C. Wyles, MD
  40. Surgical Treatment of Femoroacetabular Impingement:  Arthroscopy vs. Surgical Hip Dislocation – A Propensity Matched Analysis
    John C. Clohisy, MD
  41. Patient Reported Outcomes in Joint Registries: Defining the Optimal Collection Window
    Mohamad J. Halawi, MD
  42. When Should Complete Blood Count Tests Be Performed in Primary Total Knee Arthroplasty Patients?
    Beau J. Kildow, MD
  43. Identifiable Risk Factors to Minimize Postoperative Urinary Retention in Modern Outpatient Rapid Recover Total Joint Arthroplasty
    R. Michael Meneghini, MD
  44. Transdermal Scopolamine as an Adjunct to Multi-Modal Pain Management in Patients Undergoing Total Joint Arthroplasty
    Roshan Shah, MD
  45. Cotinine Testing Improves Smoking Cessation Prior to Total Joint Arthroplasty
    Adam Hart, MD
  46. Diabetes Mellitus Type One Poses Greater Risk for Periprosthetic Joint Infection than Type Two for Patients Undergoing Total Joint Arthroplasty
    Jeremy M. Gilliland, MD
  47. Smoking Adversely Affects Patient Reported Outcomes Following Total Joint Arthroplasty
    Mark P. Cote, PT
  48. Aspirin for Venous Thromboembolism Prophylaxis Decreases Mortality After Primary Total Joint Arthroplasty
    Alexander J. Rondon, MD, MBA
  49. Are Patients More Satisfied with a Balanced TKA?
    Gregory J. Golladay, MD
  50. Emergency Department Visit Within One Year Prior to Elective Total Joint Arthroplasty is Predictive of Postoperative Return to Emergency Department Within 90 Days
    Michael D. Gabbard, MD
  51. Unintended BPCI Consequences Following Removal of TKA from Inpatient-Only List
    Brian M. Curtin, MD, MS
  52. Age and Frailty Influence Hip and Knee Arthroplasty Reimbursement in a Bundled Payment Care Improvement Initiative
    Andrew M. Pepper, MD
  53. Perioperative Orthopaedic Surgical Home (POSH): Optimization of High-Risk TJA Candidates Is Effective
    Afshin A. Anoushiravani, MD
  54. Medical Malpractice Litigation Following Primary Total Joint Arthroplasty: A Comprehensive, Nationwide Analysis for the Last Decade
    Linsen T. Samuel, MD, MBA
  55. Preoperative Optimization Checklists Within the CJR Bundle Have Not Decreased Hospital Returns
    Sean P. Ryan, MD
  56. Antibiotic-Loaded Bone Cement in Primary Total Knee Arthroplasty: Utilization Patterns and Impact on Complications Using a National Database
    Darwin Chen, MD


Symposium Abstracts in Order of Presentation

  1. Symposium I: Simplifying the Concepts of the Hip-Spine Relationship for THA 
    Moderator: Matthew P. Abdel, MD
    Faculty: Lawrence D. Dorr, MD; Jonathan M. Vigdorchik, MD; Douglas E. Padgett, MD
  2. Symposium II : The Comprehensive Management of the Bariatric Patient: Perspectives from Bariatric and Orthopaedic Surgeons 
    Moderator: Mark I. Froimson, MD, MBA
    Faculty: Bryan D. Springer, MD; Raul J. Rosenthal, MD, FACS, FASMBS; John M. Morton, MD, MPH, FACS, FASMBS
  3. Symposium III Partial Knee Arthroplasty: Should We Be Doing More? 
    Moderator: Adolph V. Lombardi Jr., MD, FACS
    Faculty: Andrew D. Pearle, MD; William A. Jiranek, MD; Jess H. Lonner, MD
  4. Symposium IV: Revision Total Hip Arthroplasty: How I Manage the Most Common Problems I See
    Moderator: Craig J. Della Valle, MD
    Faculty: Tad M. Mabry, MD; Javad Parvizi, MD; Benjamin M. Stronach, MD; Luigi Zagra, MD
  5. Symposium V: Practice Norms in Primary Hip and Knee Arthroplasty: What is Everyone Else Doing?  
    Article-in-Press Published in the JOA, “Current Practice Trends in Primary Hip and Knee Arthroplasties Among Members of the American Association of Hip and Knee Surgeons: A Long-Term Update”
    Moderator: Daniel J. Berry, MD
  6. Symposium VI: Periprosthetic Joint Infection in Hip and Knee Arthroplasty
    Moderator: Fares S. Haddad, BSc, MD(Res), FRCS
    Faculty: Matthew S. Austin, MD; Denis Nam, MD, MSc; Andrew R. Manktelow, FRCS
  7. Symposium VII: Outpatient Joint Replacement: Practical Guidelines for Your Program Based on Evidence, Success, and Failures
    Moderator: R. Michael Meneghini, MD
    Faculty: Alexander Sah, MD; William G. Hamilton, MD; Charles A. DeCook, MD
  8. Symposium VIII: Taper Corrosion in Total Hip Arthroplasty: Applying the Best Evidence into Practice
    Moderator: Joshua J. Jacobs, MD
    Faculty: Brian J. McGrory, MD; Brett R. Levine, MD; Young-Min Kwon, MD, PhD
Close Bitnami banner